Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.260 | 0.260 | 0.000 |
Stocks | 99.740 | 99.740 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.289 | 21.763 |
Price to Book | 3.281 | 3.992 |
Price to Sales | 3.160 | 2.262 |
Price to Cash Flow | 13.336 | 16.892 |
Dividend Yield | 2.952 | 1.344 |
5 Years Earnings Growth | 8.465 | 11.322 |
Number of long holdings: 26
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Merck&Co | US58933Y1055 | 8.08 | 126.11 | -2.61% | |
Novartis | CH0012005267 | 6.53 | 91.11 | -1.00% | |
J&J | US4781601046 | 6.27 | 144.40 | -1.75% | |
Pfizer | US7170811035 | 6.02 | 28.32 | -1.96% | |
Roche Holding Participation | CH0012032048 | 5.60 | 228.80 | -0.48% | |
Eli Lilly | US5324571083 | 4.32 | 807.85 | +0.05% | |
Daiichi Sankyo | JP3475350009 | 4.20 | 5,495.0 | -2.35% | |
Novo Nordisk B | DK0062498333 | 4.07 | 915.7 | -0.43% | |
Moderna | US60770K1079 | 3.86 | 153.20 | -8.05% | |
GSK plc | GB00BN7SWP63 | 3.79 | 1,740.00 | -1.94% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Seligson Co Global Top 25 Brands Fu | 716M | 8.56 | 8.67 | 13.08 | ||
Seligson & Co Global Top 25 Brands | 716M | 8.56 | 8.66 | 13.04 | ||
Seligson North American B | 466.52M | 14.56 | 14.20 | 14.73 | ||
Seligson & Co North American A | 466.52M | 14.56 | 14.21 | 14.74 | ||
Seligson & Co Europe Index Fund A | 281.06M | 7.96 | 8.51 | 7.01 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review